Table 2.
Summary of outcomes of clinical trials utilizing SR for diabetes and weight control
| FBS (mg/dl) Pre intervention | Post intervention | HbA1C (%) Pre intervention | Post intervention | BMI (Kg/m2) Pre intervention | Post intervention | ||
|---|---|---|---|---|---|---|---|
| Kajimoto et al. (2000) [28] | Group A SRE | 140 + − 14.6 | 125.7 + −18.6* | 6.6 + − 0.2 | 6.52 + − 0.67 | 24.1 + − 4.4 | 23.5 + − 3.8* |
| Placebo | 125.7 + − 18.6 (CO) | 131.6 + − 22.4* | 6.59 + − 0.65 | 23.5 + − 3.8 (CO) | 23.5 + − 3.8 | ||
| Group B SRE | 139 + − 12.2 | 120 + − 16* | 6.6 + − 0.2 | 6.46 + − 0.38* | 22.8 + − 0.8 | 22.3 + − 2.4* | |
| Placebo | 139 + −20.4 | 6.60 + − 0.4 | 22.7 + − 2.5 | ||||
| Jayawardena et al. (2005) [29] | SR | - | - | 6.8 + −0.9 | 6.29 + − 1.02* | - | - |
| Placebo | - | - | 6.8 + − 0.9 | 6.65 + − 1.04 | - | - | |
| Shivaprasad et al. (2013) [30] | SR Root bark | 115.2 + − 1.35 | 98.4 + −2.96* | - | - | - | - |
| SR Leaves | 115.5 + − 1.43 | 95.9 + − 2.5* (At 6 weeks) | |||||
| Placebo | 116.1 + − 1.76 | 109.2 + − .5 (At 6 weeks) | - | - | - | - | |
| Ofner et al. (2013) [31] | SR (Group B) | - | - | - | - | 31.2 + − 4.7 | 29.3 + −4.5* |
| Exercise only (Group A) | - | - | - | - | 30.0 + − 5.3 | 29.4 + − 9.7 |
*denotes a statistical significance of P <0.05.
CO: at crossover.